AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 51 | 4,072 | 0 |
| Gross Profit | N/A | N/A | 51 | 4,072 | N/A |
| Operating Expenses | 18,962 | 18,989 | 19,399 | 18,008 | 20,566 |
| Operating Income | -18,962 | -18,989 | -19,348 | -13,936 | -20,566 |
| Interest Expense | 30 | 105 | -5 | 80 | 131 |
| Other Income | 270 | 171 | -54 | 29 | 357 |
| Pre-tax Income | -18,722 | -18,923 | -19,397 | -13,986 | -20,339 |
| Income Tax | 3 | 3 | 2 | 4 | 3 |
| Net Income Continuous | -18,725 | -18,926 | -19,399 | -13,990 | -20,342 |
| Net Income | $-18,725 | $-18,926 | $-19,399 | $-13,990 | $-20,342 |
| EPS Basic Total Ops | -0.22 | -0.23 | -0.24 | -0.17 | -0.24 |
| EPS Basic Continuous Ops | -0.22 | -0.23 | -0.23 | -0.17 | -0.24 |
| EPS Diluted Total Ops | -0.22 | -0.23 | -0.24 | -0.17 | -0.24 |
| EPS Diluted Continuous Ops | -0.22 | -0.23 | -0.23 | -0.17 | -0.24 |
| EBITDA(a) | $-18,342 | $-18,373 | $-18,692 | $-13,337 | $-19,999 |